ENTELOS ANNOUNCES EXPANDED COLLABORATION WITH JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT

Entelos, Inc., a leader in predictive biosimulation technologies for drug discovery, development, and commercialization, announced today that it has expanded its research collaboration with Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD) to include multiple therapeutic areas over a five-year term.

Finanztreff.de (http://www.finanztreff.de/ftreff/news.htm?id=24640152&r=0&sektion=nachrichten&awert=&u=0&k=0)